Reply

Affiliations

¹ Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China Vascular Surgery Institute of Fudan University, Shanghai, China.
² Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China Vascular Surgery Institute of Fudan University, Shanghai, China; Department of Vascular Surgery, Xiamen Branch, Zhongshan hospital, Fudan University, Xiamen, China.

Free article

Comment

Wei Zhang et al. J Vasc Surg. 2022 Jan.

Free article

. 2022 Jan;75(1):386-387.

doi: 10.1016/j.jvs.2021.09.018.

¹ Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China Vascular Surgery Institute of Fudan University, Shanghai, China.
² Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China Vascular Surgery Institute of Fudan University, Shanghai, China; Department of Vascular Surgery, Xiamen Branch, Zhongshan hospital, Fudan University, Xiamen, China.

No abstract available

Comment on

Surgical outcomes and factors associated with malignancy in carotid body tumors.
Zhang W, Liu F, Hou K, Shu X, Chen B, Wang L, Guo D, Fu W. Zhang W, et al. J Vasc Surg. 2021 Aug;74(2):586-591. doi: 10.1016/j.jvs.2020.12.097. Epub 2021 Feb 4. J Vasc Surg. 2021. PMID: 33548423
Carotid paraganglioma patients should be tested for gene mutations.
Cohnert T, Konstantiniuk P. Cohnert T, et al. J Vasc Surg. 2022 Jan;75(1):386. doi: 10.1016/j.jvs.2021.08.088. J Vasc Surg. 2022. PMID: 34949389 No abstract available.